HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rifampin and pyrazinamide for latent tuberculosis infection: clinical trials and general practice.

AuthorsJussi Saukkonen
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 39 Issue 4 Pg. 566-8 (Aug 15 2004) ISSN: 1537-6591 [Electronic] United States
PMID15356823 (Publication Type: Comment, Editorial, Review)
Chemical References
  • Pyrazinamide
  • Rifampin
Topics
  • Clinical Trials as Topic
  • Family Practice
  • Humans
  • Pyrazinamide (therapeutic use)
  • Rifampin (therapeutic use)
  • Tuberculosis (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: